Publication | Closed Access
T‐cell activation is associated with high‐grade serous ovarian cancer survival
11
Citations
27
References
2022
Year
T cell activation score may serve as a candidate for personalized immunotherapy in HGSOC. The application of anti-PD-1 therapy to HGSOC should be cautious.
| Year | Citations | |
|---|---|---|
Page 1
Page 1